Bumetanide: Difference between revisions

(Add dynamic SMW Indications by Condition table (auto-populated from disease pages via MedicationDose template))
(Switch SMW query from broadtable to table format for better layout with TOC)
 
(One intermediate revision by the same user not shown)
Line 61: Line 61:
  |?Has Route=Route
  |?Has Route=Route
  |?Has Population=Population
  |?Has Population=Population
  |format=broadtable
  |format=table
  |headers=plain
  |headers=plain
  |link=subject
  |mainlabel=-
  |sort=Has Indication
  |sort=Has Indication
  |limit=50
  |limit=50

Latest revision as of 21:58, 20 March 2026

General

Administration

  • Type: Loop diuretic
  • Dosage Forms: injectable solution, tablet
  • Dosage Strengths: injectable solution: 0.25mg/mL; tablet: 0.5, 1, 2mg
  • Routes of Administration: IV, PO
  • Common Trade Names: Bumex, Burinex

Adult Dosing

40mg furosemide = 20mg torsemide = 1mg bumetanide = 50 mg ethacrynic acid

  • 0.5 to 1 mg IV or 0.5-2mg PO. If inadequate response, repeat q2-3 hours to maximum of 10 mg per day

Pediatric Dosing

Safety/efficacy not established

Special Populations

  • Pregnancy Rating: C
  • Lactation risk: Infant risk cannot be ruled out
  • Renal dosing: no adjustment
  • Hepatic dosing: use lowest dose necessary, titrate slowly

Contraindications

  • Allergy to class/drug
  • Anuria
  • Hepatic coma
  • Severe electrolyte depletion

Adverse Reactions

Serious

  • SJS
  • Encephalopathy
  • Thrombocytopenia

Common

  • Hypotenchion
  • Hypouricemia, hypokalemia, hypochloremia
  • Cramps
  • Dizziness, headache
  • Nausea

Pharmacology

  • Rapid onset
  • Half-life: 1-6 hours
  • Metabolism: Partially metabolized in liver
  • Excretion: Mostly renal

Mechanism of Action

  • Inhibits the reabsorption of sodium and chloride in the ascending limb of the loop of Henle

Comments

Indications by Condition

The following table is automatically generated from disease/condition pages across WikEM.

IndicationDoseContextRoutePopulation
Volume overload1-2mg IV (equivalent to furosemide 40-80mg)Loop diuretic alternativeIVAdult

See Also

References

  1. Asare K. Management of Loop Diuretic Resistance in the Intensive Care Unit. Am J Health Syst Pharm. 2009;66(18):1635-1640.